Frazzoni M, de Bortoli N, Frazzoni L, Tolone S, Savarino V, Savarino E. Impedance-pH Monitoring for Diagnosis of Reflux Disease: New Perspectives. Dig Dis Sci. 2017 Aug; 62(8): 1881-1889.

Популярно о болезнях ЖКТ Лекарства при болезнях ЖКТ Если лечение не помогает Адреса клиник

Авторы: Frazzoni M. / de Bortoli N. / Frazzoni L. / Tolone S. / Savarino V. / Savarino E.V.

Impedance-pH Monitoring for Diagnosis of Reflux Disease: New Perspectives

Marzio Frazzoni1, Nicola de Bortoli2, Leonardo Frazzoni1,3, Salvatore Tolone4, Vincenzo Savarino5, Edoardo Savarino6

Author information:
1 Digestive Pathophysiology Unit, Baggiovara Hospital, Viale Giardini 1355, 41100, Modena, Italy. marziofrazzoni @
2 Department of Translational Research and New Technology in Medicine and Surgery, University of Pisa, Pisa, Italy.
3 Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
4 General and Bariatric Surgery Unit, Department of Surgery, 2nd University of Napoli, Naples, Italy.
5 Gastroenterology Unit, Department of Internal Medicine, University of Genova, Genoa, Italy.
6 Gastroenterology Unit, Department of Surgery, Oncology and Gastroenterology, University of Padova, Padua, Italy.

Аннотация на русском языке



Heartburn is the most specific symptom of gastroesophageal reflux disease (GERD). In clinical practice, heartburn relief by a proton pump inhibitor (PPI) trial does suffice to confirm GERD. However, an objective diagnosis of GERD is required before anti-reflux endoscopic or surgical interventions, independently from PPI response. Thus, since normal findings at upper endoscopy are detected in the majority of patients with heartburn, reflux monitoring is often required. When traditional catheter-based or wireless pH tests are used, reflux episodes are conventionally identified by pH drops below 4.0 units. Combined impedance-pH monitoring has the advantage to provide a comprehensive assessment of both physical and chemical properties of refluxate and the distinction between acid and weakly acidic refluxes, both proven to cause heartburn. Unfortunately, the conventional impedance-pH parameters, namely acid exposure time and number of reflux events, are characterized by suboptimal diagnostic sensitivity, and the reliability of symptom-reflux association indexes remains questionable. Therefore, novel impedance parameters, namely the post-reflux swallow-induced peristaltic wave (PSPW) index and the mean nocturnal baseline impedance (MNBI), have recently been proposed in order to achieve a better diagnostic yield. In fact, they proved to be highly accurate in distinguishing reflux-related from reflux-unrelated heartburn, off- as well as on-PPI therapy. Currently, manual review of impedance-pH tracings is needed because of the modest accuracy of available software tools for automated analysis. PSPW index and MNBI are highly applicable and reproducible, and their calculation requires a few additional minutes during the manual review of impedance-pH tracings. So far, we believe that PSPW index and MNBI are ready for prime time and should become part of the standard analysis of impedance-pH tracings for GERD diagnosis in patients with endoscopy-negative heartburn.

Keywords: GERD; NERD; PPI; Impedance-pH monitoring; Esophageal chemical clearance; PSPW index; Esophageal baseline impedance



Area under the curve


Acid exposure time


Erosive reflux disease


Functional heartburn


Gastroesophageal reflux disease


Hypersensitive esophagus


Mean nocturnal baseline impedance


Non-erosive reflux disease


Post-reflux swallow-induced peristaltic wave


Receiver operating characteristic


Symptom association probability


Symptom index


Gastroesophageal reflux disease (GERD) develops when the reflux of gastric contents into the esophagus leads to troublesome symptoms and/or complications [1–3] and is the most common chronic upper digestive disorder encountered by the gastroenterologist. Typical GERD is defined by the presence of troublesome heartburn with/ without regurgitation [1–3]. Heartburn is the cardinal GERD symptom and consists of a burning sensation in the retrosternal area, whereas regurgitation is defined as the perception of refluxed gastric contents into the mouth [1]. Proton pump inhibitor (PPI) therapy represents the main-stay of medical treatment for typical GERD, with more than 80% of efficacy in healing reflux esophagitis and relieving heartburn [3]. Therefore, in clinical practice heartburn relief by a PPI trial is a reasonable approach to confirm GERD [3].

In the absence of alarm symptoms, diagnostic investigations are recommended in patients with PPI-refractory heartburn and in uninvestigated PPI-responsive cases before endoscopic or surgical anti-reflux interventions [3]. Since endoscopy shows erosive reflux disease (ERD) in less than one-third of patients with heartburn [4], direct reflux monitoring [5], always preceded by esophageal manometry [6], is required in the majority of cases. Most patients with endoscopy-negative heartburn are classified as non-erosive reflux disease (NERD) on the basis of abnormal results at pH or impedance-pH monitoring [4], whereas those with normal results and unsatisfactory response to a PPI trial have been defined as functional heartburn (FH) and considered as a separate entity from GERD [5].

Limitations of pH Monitoring

Reflux is traditionally assessed by means of catheter-based or wireless pH monitoring and identified by pH drops below 4.0 units. The total percentage of time with pH < 4.0, namely the acid exposure time (AET), is considered as the most useful parameter to separate physiologic from pathologic reflux [7]. Unfortunately, the AET normative values reported in different centers range widely from 3.2 to 7.2% [7]. Furthermore, normal AET values have been found in up to 30% of patients with reflux esophagitis [7].

To overcome the limitations of AET, symptom–reflux association indexes have been developed to document a cause–effect relationship between reflux episodes and symptoms [7]. Symptom association probability (SAP) and symptom index (SI), regarded as positive when [95 and [50%, respectively, are the most widely adopted in clinical practice [4]. SAP/SI positivity with normal AET defines the clinical category of hypersensitive esophagus (HE), which has been included within the realm of GERD on the basis of Rome III criteria for esophageal disorders [5].

However, reflux assessment only based on pH criteria has several limitations. In fact, it has been shown that pH drops below 4.0 units may also be due to acidic swallows, which may cause an overestimation of esophageal expo-sure to gastric contents [8]. Moreover, in vitro studies have shown that the proteolytic activity of pepsins and not hydrochloric acid per se is essential for esophageal mucosa damage to occur [9]. Proteolytic activity of pepsins is maintained up to pH 6.0 units [10], and healing of mucosal breaks occurs through reparative processes that are inhibited at pH < 6.5 units [11]. In vivo studies have shown that PPI therapy transforms acid into weakly acidic refluxes [12], which have been implicated in the pathogenesis of refractory reflux esophagitis [13] and cannot be reliably assessed by pH-only monitoring [4, 8, 12–14].

Combining esophageal bile and acid reflux monitoring does not add any relevant piece of information for GERD diagnosis [14]. It has long been recognized that bile reflux closely tracks with acid reflux and can be suppressed by PPI therapy [14]. Moreover, using the above combination, it has been shown that bile reflux does not differ between PPI-responsive and PPI-refractory GERD patients [15]. Therefore, the interest for bile reflux monitoring has waned [14].

Conventional Assessment of Impedance-pH Monitoring

The combination of pH with impedance monitoring provides a comprehensive characterization of reflux episodes based on both physical (i.e., liquid, gas, or mixed) and chemical properties of the refluxate [16]. Gastroesophageal reflux episodes are detected on the basis of characteristic impedance changes (i.e., distal to proximal progressing changes in intraluminal impedance), and data from the esophageal pH sensor are simply used to distinguish acid (nadir pH < 4) from non-acid, namely weakly acidic (nadir pH 4–7) and weakly alkaline refluxes (nadir pH > 7) [16]. No correlation between bile reflux, as measured with bile reflux monitoring, and non-acid reflux, as measured with impedance-pH monitoring, has been shown [17].

Currently, impedance-pH monitoring is regarded as the gold standard for the assessment of reflux [18]. Pilot studies have shown that assessment of SAP and SI for non-acid reflux events afforded a 16–33% diagnostic gain in patients evaluated on-PPI therapy [19–21]. On the other hand, off-PPI SAP positivity for non-acid refluxes led to a modest 10–12% diagnostic gain [22, 23]. Unfortunately, patients frequently do not perceive symptoms during a 24-h impedance-pH study and/or admit inaccurate symptom recording, so that SAP and SI represent overly patient-dependent variables. Furthermore, SAP and SI do not measure the severity and clinical impact of symptoms. For instance, nocturnal heartburn and regurgitation may interrupt sleep and are undoubtedly troublesome symptoms, but SAP and SI may nonetheless result negative because they are calculated for the entire 24-h monitoring period. Moreover, SAP and SI positivity is determined by chance when reflux rates are low [24], so that their clinical value is questionable.

In addition to AET and SAP/SI, the number of total (acidic, weakly acidic, and weakly alkaline) reflux events can be reliably assessed at impedance-pH monitoring and represents a parameter scarcely affected by PPI therapy [12]. An abnormal number of reflux events at on-PPI impedance-pH monitoring is predictive of an abnormal AET, as confirmed by off-PPI wireless pH monitoring [25]. In a study performed on-PPI therapy, the assessment of the number of reflux events combined with SAP and SI allowed to diagnose PPI-refractory NERD in two-thirds of cases, as opposed to less than half of cases by assessing SAP/SI only [26]. Objectively documented positive surgical outcome has confirmed the diagnostic specificity of the on-PPI number of reflux events, as combined with SAP/SI positivity for weakly acidic refluxes, in patients with PPI-refractory typical GERD [27–29].

Novel Impedance Parameters

Antegrade and retrograde bolus transit of both liquid and gas [14, 16, 18] can be evaluated by impedance monitoring. In addition to detection of all types of reflux events, impedance monitoring also allows assessment of esophageal clearance of gastroesophageal reflux, which is biphasic, including both volume and chemical clearance [30, 31].

Volume clearance consists of a secondary peristaltic wave, which is elicited by esophageal stretch receptors and removes around 90% of the refluxate, determining the end of a reflux episode [32]. At impedance monitoring, volume clearance can be evaluated with bolus clearance time and percent bolus exposure, but these parameters did not prove to be clinically useful [33].

Chemical clearance consists of a salivary swallow, elicited by an esophago-salivary vagal reflex and delivering salivary bicarbonate and epidermal growth factor to the esophagus, so that distal esophageal pH increases and repair of reflux-induced mucosal damage can occur [11, 30]. After the end of a reflux episode, an impedance drop originating in the upper esophagus and reaching the lower part of the organ signals the peristaltic transit of saliva [34] and has been defined as a post-reflux swallow-induced peristaltic wave (PSPW) [35]. To limit overlap with spontaneous swallowing (64 swallows per hour, approximately 1 per min during the daytime period) [36], only PSPWs occurring within 30 s from the end of reflux episodes (Fig. 1) are considered for calculation of the PSPW index, a new parameter which is obtained dividing the number of refluxes followed within 30 s by a PSPW by the number of total refluxes [35]. The PSPW index has been shown to efficiently separate ERD from NERD patients and both from healthy subjects at off-PPI impedance-pH monitoring, as well as ERD from NERD patients and both from patients with FH at on-PPI impedance-pH monitoring [35]. These results demonstrated that the esophago-salivary reflex can be elicited by acidic and weakly acidic refluxes as well. Accordingly, in patients with PPI-refractory heartburn on-therapy PSPW index was significantly lower in PPI-refractory reflux esophagitis than in healed reflux esophagitis and in NERD, and was the only impedance-pH parameter associated with PPI-refractory mucosal damage [37]. Moreover, at on-PPI impedance-pH monitoring lower values of PSPW index were the only impedance-pH parameter associated with neoplastic progression, i.e., incident dysplasia at 3-year follow-up, in patients with Barrett’s esophagus on continuous PPI treatment [38]. These results strongly suggest that impairment of chemical clearance plays a key role in the pathogenesis of reflux-induced esophageal mucosal damage.

Fig. 1 Post-reflux swallow-induced peristaltic wave (PSPW). Impedance-pH tracing — an acidic reflux episode is followed within 30 s by an impedance drop from the proximal to the distal esophagus (red arrow), which represents a post-reflux swallow-induced peristaltic wave (PSPW)

Impedance monitoring also allows the measurement of baseline impedance: low values, unaffected by circadian variations [39], reflect reflux-induced impairment of mucosal integrity even in the absence of macroscopic damage [40]. It has been shown that the mean of three 10-minute nighttime periods, selected avoiding reflux episodes, swallows, and pH drops (Fig. 2), accurately reflects the 6-h nocturnal bedtime period, which is less influenced by swallowing activity as opposite to the diurnal one [41]. In endoscopy-negative heartburn patients with normal AET and negative SAP/SI, lower values of mean nocturnal baseline impedance (MNBI) have been found in patients with PPI-responsive heartburn as compared to those with PPI-refractory heartburn [42]. These findings confirm that conventional impedance-pH variables are not accurate enough for separation of GERD from FH.

Fig. 2 Mean nocturnal baseline impedance (MNBI). a Impedance-pH tracing — a 10-min nighttime recumbent period, avoiding swallows, refluxes, and pH drops, has been selected. The Ohms icon has been clicked with opening of a cascade menu, and then Zero (black arrow) is clicked. b The baseline impedance values of the selected period are now displayed. The values from the most distal impedance channel (red arrow) at three time points (around 1.00, 2.00, and 3.00 am) are summed and the mean calculated to obtain MNBI

In a multicenter off-therapy impedance-pH study, the PSPW index and MNBI distinguished 68 ERD and 221 NERD patients from 50 healthy controls with higher diagnostic accuracy than conventional impedance-pH parameters [43]. By means of receiver operating characteristic (ROC) analysis, optimal cutoff values for PSPW index (61%) and MNBI (2292 Ohms) were defined. The area under the curve (AUC) of the PSPW index (0.977) was excellent (>0.9) and significantly greater than that of all the other impedance-pH parameters [43]. In NERD cases, PSPW index and MNBI showed a higher sensitivity and better overall diagnostic accuracy in comparison with AET, number of reflux events, and percent bolus exposure. NERD diagnosis was confirmed by conventional pH-only criteria in 75% of cases, and by impedance-pH criteria, including PSPW index and MNBI, in 98% cases (P = 0.001) [43]. The results of this study, showing the significant diagnostic gain afforded by PSPW index and MNBI while confirming the pitfalls of conventional impedance-pH parameters (Table 1), were regarded as emphasizing the clinical value of impedance-pH monitoring [33].

Table 1 Pitfalls of conventional of impedance-pH parameters in patients with endoscopy-negative heartburn







High variability of normative values at different centers

Day-to-day variability

Low sensitivity




Symptoms may not occur




Patients frequently admit inaccurate recording

Positivity is determined by chance when reflux rates are low

Uncertain significance of discordant results

Severity and clinical relevance of symptoms are not measured

Reflux events



Low sensitivityb

Percent bolus exposure



Low sensitivityb

Unsatisfactory heartburn response to a PPI trial, normal AET and negative SAP/SI define functional heartburn  

AET acid exposure time, NERD non-erosive reflux disease, HE hypersensitive esophagus, SAP symptom association probability, SI symptom index
a Kahrilas and Quigley [7]
b Frazzoni et al. [43]


Recently, Rome IV criteria for esophageal disorders have defined NERD on the basis of abnormal AET only [44]. HE, defined by positive SAP/SI with normal AET, has been separated from GERD and included within the spectrum of functional esophageal disorders, differently from Rome III criteria [44]. Heartburn relief by PPIs as a criterion for defining GERD has been tempered because of the reportedly high placebo response and limited predictive value [44]. However, it can be argued that the moderate diagnostic sensitivity of AET can have influenced the reportedly [45] moderate diagnostic yield of a PPI trial. The negative results of a diagnostic test in the presence of a definite responsiveness of typical symptoms to a specific therapy should stimulate the search for more efficient diagnostic methods.

After Rome III criteria, both electron [46] and light [47] microscopy studies have shown that microscopic esophagitis is much more frequently detected in patients with HE than in those with FH. In a recent study, PSPW index and MNBI were significantly lower in patients with endoscopy-negative PPI-responsive heartburn as compared to patients with endoscopy-negative PPI-refractory heartburn [48]. At multivariate logistic regression analysis, PSPW index and MNBI were independent predictors of HE, defined as PPI-responsive heartburn with normal AET [48]. At ROC analysis, combined assessment of PSPW index and MNBI allowed excellent separation of HE from FH (AUC 0.957); SAP/SI positivity was found in 62% of HE patients, whereas PSPW index/MNBI positivity was found in 92% of them (P < 0.0001) [48]. Therefore, the calculation of PSPW index and MNBI affords diagnosis of HE independently of and significantly better than SAP/SI positivity. Impairment of chemical clearance, as shown by low PSPW index [48], and loss of mucosal integrity, as documented by low MNBI values [48] and by microscopic esophagitis [46, 47], can explain the increased perception of reflux events and the PPI responsiveness in patients with HE [41–43], suggesting that they really belong to the GERD spectrum and cannot be displaced to the group of patients with esophageal functional disorders.

Recently, Patel et al. [49] showed that low MNBI values, as detected at off-PPI impedance-pH monitoring, represent an independent predictor of GERD response to both medical and surgical treatment. Assessment of MNBI can also be useful at on-PPI impedance-pH monitoring [50]. We found significantly lower values of MNBI and PSPW index in PPI-refractory heartburn patients with persisting reflux esophagitis than in those with healed reflux esophagitis and NERD, and in all these three GERD subgroups than in FH [50]. The comparison of NERD with FH showed high AUCs pertaining to MNBI and PSPW index at ROC analysis (0.677 and 0.886, respectively) [50]. Noteworthy, at multivariate logistic regression analysis the PSPW index was an independent predictor of PPI-refractory GERD as confirmed by the positive surgical outcome, defined by normal conventional impedance-pH findings at 3-year follow-up [50].

How to Monitor Reflux: Off- or On-PPI Therapy?

Impedance-pH monitoring has been recommended in patients with PPI-refractory reflux symptoms and before anti-reflux endoscopic or surgical interventions [3, 14, 51, 52]; moreover, considering the current concerns about PPI safety [53], objective GERD diagnosis may be required in patients with PPI-dependent heartburn to justify long-term PPI need and prescription.

GERD diagnosis may be missed if based only on the analysis of conventional impedance-pH variables, and it has been recognized that the PSPW index and MNBI may enhance the diagnostic yield of impedance-pH monitoring [33, 54]. Heartburn is a highly specific GERD symptom [1–3], and PSPW index and MNBI have shown high diagnostic accuracy both on- and off-PPI therapy. Impedance-pH monitoring should be performed on-PPI therapy when the clinical questions are to distinguish between reflux-related and reflux-unrelated PPI-refractory heartburn and to find the reasons for PPI refractoriness, e.g., poor compliance, inadequate acid suppression, or high burden of weakly acidic refluxes. On the other hand, when GERD diagnosis is still in doubt, but must be firmly confirmed, e.g., before anti-reflux endoscopic or surgical interventions, impedance-pH testing should be performed after two-week PPI washout (Fig. 3).

Fig. 3 Algorithm for GERD diagnosis in endoscopy-negative heartburn. Positive response to a PPI trial (standard or high dosage, up to 8 weeks) is sufficient for a presumptive GERD diagnosis. Heartburn refractory to 8-week high-dosage PPI dictates on-therapy impedance-pH monitoring to clarify the mechanism(s) of PPI refractoriness and distinguish reflux-related from reflux-unrelated PPI-refractory heartburn. Impedance-pH monitoring must always be preceded by esophageal manometry. Before anti-reflux surgical or endoscopic interventions, doubtful diagnoses must be confirmed by off-therapy impedance-pH testing after two-week PPI withdrawal. PPI proton pump inhibitor, GERD gastroesophageal reflux disease, PSPW post-reflux swallow-induced peristaltic wave, MNBI mean nocturnal baseline impedance, AET acid exposure time, SAP symptom association probability, SI symptom index

PSPW Index and MNBI: Ready for Prime Time?

We have shown high diagnostic accuracy, reproducibility, and applicability of PSPW index and MNBI [35, 41–43, 48, 50]. Calculation is easy to perform, and cutoff normative values have been established with ROC analysis [43] (Table 2). Of note, several studies from other groups have emphasized the clinical value of intraluminal baseline impedance [39, 40, 49, 55, 56] and of chemical clearance [34, 57] assessment.

Table 2 Assessment, calculation, and normal values of PSPW index and MNBI at impedance-pH monitoring



Normal values

PSPW index

Reflux events followed by a PSPW within 30 s are summed by means of a digital counter, while the number of total refluxes is automatically provided by the software at the end of the manual review

Number of total refluxes followed by a PSPW within 30 s divided by the number of total refluxes



Selection of three 10-min nighttime recumbent periods with avoidance of reflux events, pH drops and swallows

Baseline impedance values in the three periods are summed, and the mean is calculated

>2292 Ohmsa

PSPW post-reflux swallow-induced peristaltic wave, MNBI mean nocturnal baseline impedance
a Frazzoni et al. [43]

Concerns have been raised about the necessity of a manual review of the entire impedance-pH study to calculate the PSPW index [33]. However, careful manual review of impedance-pH tracings is routinely warranted to calculate conventional  variables, because automatic software analysis is hindered by a considerable error rate and does not guarantee accurate results [58–60].

Calculation of PSPW index and MNBI requires a few minutes during the manual analysis of tracings [35, 41]. It is important to underline that any extra-time required for calculation of PSPW index and MNBI is justified when the clinical issue is a reliable diagnosis of GERD, especially when patients are candidate for anti-reflux surgical or endoscopic interventions. Further, we are quite confident that future releases of software analysis will incorporate automatic methods to assess these parameters, as occurred in the past with symptom–reflux association analysis.

In our opinion, PSPW index and MNBI are ready for prime time and should be routinely assessed in patients with endoscopy-negative heartburn evaluated with impedance-pH monitoring. Whether PSPW index and MNBI can improve the diagnostic yield of impedance-pH monitoring also in patients with non-cardiac chest pain and extra-esophageal symptoms suspected to be due to GERD is an open issue to be assessed in future studies.


Impedance-pH monitoring provides the most comprehensive assessment of gastroesophageal reflux. The diagnostic sensitivity and reliability of conventional impedance-pH variables, namely AET, SAP, SI, number of reflux events, and percent bolus exposure, is suboptimal. PSPW index and MNBI are objective and reliable parameters, which significantly and consistently increase the diagnostic yield of impedance-pH monitoring, both off- and on-PPI therapy, in patients with PPI-responsive and PPI-refractory heartburn. We propose that analyses of the PSPW index and MNBI become part of the standard assessment of impedance-pH tracings for GERD diagnosis in patients with endoscopy-negative heartburn.


Funding The manuscript was prepared without any financial or technical support.
Author's contributions MF wrote the manuscript. N de B, LF, ST, VS, ES critically revised the manuscript.
Compliance with ethical standards
Conflict of interest The authors have no conflict of interest to declare.


1. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R, and the Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900–1920.

2. Kahrilas P, Shaheen N, Vaezi M. American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease. Gastroenterology. 2008;135:1392–1413.

3. Katz P, Gerson L, Vela M. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108:308–328.

4. Savarino E, Zentilin P, Savarino V. NERD: an umbrella term including heterogeneous subpopulations. Nat Rev Gastroenterol Hepatol. 2013;10:371–380.

5. Galmiche JP, Clouse RE, Balint A, et al. Functional esophageal disorders. Gastroenterology. 2006;130:1459–1465.

6. Savarino E, De Bortoli N, Bellini M, et al. Practice guidelines on the use of esophageal manometry—a GISMAD-SIGE-AIGO medical position statement. Dig Liver Dis. 2016;48:1124–1135.

7. Kahrilas PJ, Quigley EMM. Clinical esophageal pH recording: a technical review for practice guideline development. Gastroenterology. 1996;110:1982–1996.

8. Hila A, Agrawal A, Castell DO. Combined multichannel intraluminal impedance and pH esophageal testing compared to pH alone for diagnosing both acid and weakly acidic gastroesophageal reflux. Clin Gastroenterol Hepatol. 2007;5:172–177.

9. Roberts NB. Review article: human pepsins—their multiplicity, function and role in reflux disease. Aliment Pharmacol Ther. 2006;24:2–9.

10. Pearson JP, Parikh S. Review article: nature and properties of gastro-oesophageal and extra-oesophageal refluxate. Aliment Pharmacol Ther. 2011;33:2–7.

11. Orlando RC. Review article: oesophageal tissue damage and protection. Aliment Pharmacol Ther. 2011;33:8–12.

12. Frazzoni M, Savarino E, Manno M, et al. Reflux patterns in patients with short segment Barrett’s oesophagus: a study using impedance-pH monitoring off and on proton pump inhibitor therapy. Aliment Pharmacol Ther. 2009;30:508–515.

13. Frazzoni M, Conigliaro R, Melotti G. Weakly acidic refluxes have a major role in the pathogenesis of proton pump inhibitor-resistant reflux oesophagitis. Aliment Pharmacol Ther. 2011;33:601–606.

14. Hirano I, Richter JE and the Practice Parameters Committee of the American College of Gastroenterology. ACG practice guidelines—esophageal reflux testing. Am J Gastroenterol. 2007; 102:668–685.

15. Gasiorowska A, Navarro-Rodriguez T, Wendel C, et al. Comparison of the degree of duodenogastroesophageal reflux and acid reflux between patients who failed to respond and those who were successfully treated with a proton pump inhibitor once daily. Am J Gastroenterol. 2009;104:2005–2013.

16. Tutuian R, Castell DO. Review article: complete gastro-oesophageal reflux monitoring—combined pH and impedance. Aliment Pharmacol Ther. 2006;24:27–37.

17. Pace F, Sangaletti O, Pallotta S, et al. Biliary reflux and non-acid reflux are two distinct phenomena: a comparison between 24-hour multichannel intraesophageal impedance and bilirubin monitoring. Scand J Gastroenterol. 2007;42:1031–1039.

18. Bredenoord AJ. Impedance-pH monitoring: new standard for measuring gastro-oesophageal reflux. Neurogastroenterol Motil. 2008;20:434–439.

19. Zerbib F, Roman S, Ropert A, et al. Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy. Am J Gastroenterol. 2006;101:1956–1963.

20. Mainie I, Tutuian R, Shay S, et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut. 2006;55:1398–1402.

21. Sharma N, Agrawal A, Freeman J, Vela M, Castell DO. An analysis of persistent symptoms in acid-suppressed patients undergoing impedance-pH monitoring. Clin Gastroenterol Hepatol. 2008;6:521–524.

22. Savarino E, Zentilin P, Tutuian R, et al. Role of nonacid reflux in NERD: lessons learned from impedance-pH monitoring in 150 patients off therapy. Am J Gastroenterol. 2008;103:2685–2693.

23. Savarino E, Marabotto E, Zentilin P, et al. The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease. Dig Liver Dis. 2011;43:542–547.

24. Slaughter JC, Goutte M, Rymer JA, et al. Caution about overinterpretation of symptom indexes in reflux monitoring for refractory gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2011;9:868–874.

25. Pritchett JM, Aslam M, Slaughter JC, Ness RM, Garrett CG, Vaezi MF. Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy. Clin Gastroenterol Hepatol. 2009;7:743–748.

26. Frazzoni M, Conigliaro R, Mirante VG, Melotti G. The added value of quantitative analysis of on-therapy impedance-pH parameters in distinguishing refractory non-erosive reflux disease from functional heartburn. Neurogastroenterol Motil. 2012;24:141-e87.

27. Frazzoni M, Conigliaro R, Melotti G. Reflux parameters as modified by laparoscopic fundoplication in 40 patients with heartburn/regurgitation persisting despite PPI therapy. A study using impedance-pH monitoring. Dig Dis Sci. 2011;56:1099–1106.

28. Frazzoni M, Conigliaro R, Manta R, Melotti G. Reflux parameters as modified by EsophyX or laparoscopic fundoplication in refractory GERD. Aliment Pharmacol Ther. 2011;34:67–75.

29. Frazzoni M, Piccoli M, Conigliaro R, Manta R, Frazzoni L, Melotti G. Refractory gastroesophageal reflux disease as diagnosed by impedance-pH monitoring can be cured by laparoscopic fundoplication. Surg Endosc. 2013;27:2940–2946.

30. Helm J, Dodds W, Pelc L, Palmer DW, Hogan WJ, Teeter BC. Effect of esophageal emptying and saliva on clearance of acid from the esophagus. N Engl J Med. 1984;310:284–288.

31. Shafik A, El-Sibai O, Shafik AA, Mostafa R. Effect of topical esophageal acidification on salivary secretion: identification of the mechanism of action. J Gastroenterol Hepatol. 2005;20:1935–1939.

32. Conchillo J, Smout A. Review article: intra-oesophageal impedance monitoring for the assessment of bolus transit and gastro-oesophageal reflux. Aliment Pharmacol Ther. 2009;29:3–14.

33. Gyawali CP. Redeeming clinical value of esophageal pH impedance monitoring. Clin Gastroenterol Hepatol. 2016;14:47–49.

34. Woodley FW, Fernandez F, Mousa H. Diurnal variation in the chemical clearance of acid gastroesophageal reflux in infants. Clin Gastroenterol Hepatol. 2007;5:37–43.

35. Frazzoni M, Manta R, Mirante VG, Conigliaro R, Frazzoni L, Melotti G. Esophageal chemical clearance is impaired in gastro-esophageal reflux disease—a 24 h impedance-pH monitoring assessment. Neurogastroenterol Motil. 2013;25:399-e295. /literature/authors/10162

36. Bredenoord AJ, Weusten BLAM, Timmer R, Smout AJPM. Reproducibility of multichannel intraluminal electrical impedance monitoring of gastroesophageal reflux. Am J Gastroenterol. 2005;100:265–269.

37. Frazzoni M, Bertani H, Manta R, et al. Impairment of chemical clearance is relevant to the pathogenesis of refractory reflux oesophagitis. Dig Liver Dis. 2014;46:596–612.

38. Frazzoni M, Bertani H, Conigliaro R, Frazzoni L, Losi L, Melotti G. Neoplastic progression in short-segment Barrett’s oesophagus is associated with impairment of chemical clearance, but not inadequate acid suppression by proton pump inhibitor therapy. Aliment Pharmacol Ther. 2014;40:835–842.

39. Kessing BF, Bredenoord AJ, Weijenborg PW, Hemmink GJ, Loots CM, Smout AJ. Esophageal acid exposure decreases intraluminal baseline impedance. Am J Gastroenterol. 2011;106:2093–2097.

40. Farrè R, Blondeau K, Clement D, et al. Evaluation of oesophageal mucosa integrity by the intraluminal impedance technique. Gut. 2011;60:885–892.

41. Martinucci I, De Bortoli N, Savarino E, et al. Esophageal baseline impedance levels in patients with pathophysiological characteristics of functional heartburn. Neurogastroenterol Motil. 2014;26:546–555.

42. De Bortoli N, Martinucci I, Savarino E, et al. Association between baseline impedance values and response proton pump inhibitors in patients with heartburn. Clin Gastroenterol Hepatol. 2015;13:1082–1088.

43. Frazzoni M, Savarino E, De Bortoli N, et al. Analyses of the post-reflux swallow-induced peristaltic wave index and nocturnal baseline impedance parameters increase the diagnostic yield of patients with reflux disease. Clin Gastroenterol Hepatol. 2016;14:40–46.

44.Aziz Q, Fass R, Gyawali CP, Miwa H, Pandolfino JE, Zerbib F. Functional esophageal disorders. Gastroenterology. 2016;150:1368–1379.

45. Dent J, Vakil N, Jones R, et al. Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the diamond study. Gut. 2010;59:714–721.

46. Vela MF, Craft BM, Sharma N, Freeman J, Hazen-Martin D. Refractory heartburn: comparison of intercellular space diameter in documented GERD vs. functional heartburn. Am J Gastroenterol. 2011;106:844–850.

47. Savarino E, Zentilin P, Mastracci L, et al. Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn. J Gastroenterol. 2013;48:473–482.

48. Frazzoni M, de Bortoli N, Frazzoni L, et al. Impairment of chemical clearance and mucosal integrity distinguishes hypersensitive esophagus from functional heartburn. J Gastroenterol. 2017;52:444–451.

49. Patel A, Wang D, Salnani N, Sayuk GS, Gyawali CP. Distal mean nocturnal baseline impedance on pH-impedance monitoring predicts reflux burden and symptomatic outcome in gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2016;44:890–898.

50. Frazzoni M, De Bortoli N, Frazzoni L, et al. The added diagnostic value of postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance in refractory reflux disease studied with on-therapy impedance-pH monitoring. Neurogastroenterol Motil. 2017;29:e12947.

51. Sifrim D, Zerbib F. Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors. Gut. 2012;61:1340–1354.

52. Zerbib F, Sifrim D, Tutuian R, Attwood S, Lundell L. Modern medical and surgical management of difficult-to-treat GORD. United Eur Gastroenterol J. 2013;1:21–31.

53. Savarino V, Dulbecco P, Savarino E. Are proton pump inhibitors really so dangerous? Dig Liver Dis. 2016;48:851–859.

54. Ravi K, Katzka DA. Esophageal impedance monitoring: clinical pearls and pitfalls. Am J Gastroenterol. 2016;111:1245–1256.

55. Zhong C, Duan L, Wang K, et al. Esophageal intraluminal baseline impedance is associated with severity of acid reflux and epithelial structural abnormalities in patients with gastroesophageal reflux disease. J Gastroenterol. 2013;48:601–610.

56. Kandulski A, Weigt J, Caro C, et al. Esophageal intraluminal baseline impedance differentiates gastroesophageal reflux disease from functional heartburn. Clin Gastroenterol Hepatol. 2015;13:1075–1081.

57. Cho YK, Lee JS, Lee TH, et al. The relationship of the post-reflux swallow-induced peristaltic wave index and esophageal baseline impedance with gastroesophageal reflux disease symptoms. J Neurogastroenterol Motil. 2017;23:237–244.

58. Roman S, Bruley Des Varannes S, Pouderoux P, et al. Ambulatory 24-h oesophageal impedance—pH recordings: reliability of automatic analysis for gastro-oesophageal reflux assessment. Neurogastroenterol Motil. 2006;18:978–986.

59. Ravi K, DeVault KR, Murray JA, Bouras EP, Francis D. Inter-observer agreement for multichannel intraluminal impedance-pH testing. Dis Esophagus. 2010;23:540–544.

60. Hemmink GJ, Bredenoord AJ, Aanen MC, Weusten BL, Timmer R, Smout AJ. Computer analysis of 24-h esophageal impedance signals. Scand J Gastroenterol. 2011;46:271–276.

Назад в раздел
Популярно о болезнях ЖКТ читайте в разделе "Пациентам"
Лекарства, применяемые при заболеваниях ЖКТ
Адреса клиник

Логотип Исток-Системы

Информация на сайте предназначена для образовательных и научных целей. Условия использования.